ATE535239T1

Formulations containing amiodarone and sulfoalkyl ether cyclodextrin

Abstract

This record has no abstract on file.

Term ended

Projected expiry passed 29 April 2023, 3.4 years ago.

32 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims
Document	Office	Kind	Date
13962002	United States of America	A	2002-05-04
0313250	United States of America	W	2003-04-29

Family members, oldest first
Document	Office	Kind
CA2483774A1	Canada	A1	2003-11-13
WO03092590A2	World Intellectual Property Organization (WIPO)	A2	2003-11-13
AU2003234285A1	Australia	A1	2003-11-17
US2003216353A1	United States of America	A1	2003-11-20
WO03092590A3	World Intellectual Property Organization (WIPO)	A3	2004-01-22
KR20040106452A	Republic of Korea	A	2004-12-17
EP1501496A2	European Patent Office (EPO)	A2	2005-02-02
MXPA04010925A	Mexico	A	2005-02-14
US6869939B2	United States of America	B2	2005-03-22
JP2005530744A	Japan	A	2005-10-13
IL165022A0	Israel	A0	2005-12-18
EP1501496A4	European Patent Office (EPO)	A4	2006-05-31
AU2003234285B2	Australia	B2	2007-01-04
KR100984197B1	Republic of Korea	B1	2010-09-28
JP2011116776A	Japan	A	2011-06-16
CA2483774C	Canada	C	2011-07-19
IL165022A	Israel	A	2011-08-31
JP4764004B2	Japan	B2	2011-08-31
EP1501496B1	European Patent Office (EPO)	B1	2011-11-30
AT535239T	Austria	T	2011-12-15
ATE535239T1This record	Austria	T1	2011-12-15
EP2402008A1	European Patent Office (EPO)	A1	2012-01-04
PT1501496E	Portugal	E	2012-02-20
DK1501496T3	Denmark	T3	2012-03-19
ES2378306T3	Spain	T3	2012-04-11
SI1501496T1	Slovenia	T1	2012-04-30
JP5656692B2	Japan	B2	2015-01-21
EP2402008B1	European Patent Office (EPO)	B1	2016-01-27
ES2567716T3	Spain	T3	2016-04-26
DK2402008T3	Denmark	T3	2016-05-02
SI2402008T1	Slovenia	T1	2016-05-31
HUE027551T2	Hungary	T2	2016-10-28